Zim Laboratories Ltd
Q1 FY27, unaudited
- Revenue
- ₹93.05 Cr
- Profit after tax
- ₹-3.88 Cr
As filed with the exchange, standalone basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 93.05 | +30.27% | 370.48 |
| Other income | 0.99 | −33.21% | 11.39 |
| Total income | 94.03 | +28.98% | 381.87 |
| Employee benefit expense | 18.14 | +33.61% | 60.10 |
| Finance costs | 3.64 | +10.29% | 13.20 |
| Depreciation & amortisation | 5.17 | +7.95% | 19.37 |
| Total expenses | 99.46 | +32.28% | 373.47 |
| Profit before tax | -5.42 | −137.51% | 8.40 |
| Tax expense | -1.55 | −161.71% | 2.44 |
| Profit after tax | -3.88 | −129.06% | 5.97 |
| Total comprehensive income | -3.90 | −113.52% | 5.87 |
| Earnings per share, basic | ₹-0.72 | ₹1.22 |
|---|---|---|
| Earnings per share, diluted | ₹-0.72 | ₹1.22 |
Earnings call
Q4 FY26Zim Laboratories reported full year FY26 total operating income of approximately INR 3,744 million, broadly flat versus FY25, which management attributed to an estimated INR 20-25 crore revenue impact from MENA geopolitical disruption and continued EU GMP related constraints on the regulated pipeline. The company underwent an EU GMP re-inspection by German and Portuguese authorities from May 4-7, 2026, and management said the CAPA implementation is substantially complete with a positive outcome expected. Q4 FY26 EBITDA margin was approximately 12.7% and full year PAT stood at INR 58 million, with exports contributing approximately 82% of quarterly operating income.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Filings
12 shown · 46 published by the exchange
12 Aug 2026
Transcript12 Aug 2026
12 Aug 2026
08 Aug 2026
07 Aug 2026
Filing06 Aug 2026
Presentation06 Aug 2026
06 Aug 2026
04 Aug 2026
31 Jul 2026
30 Jul 2026
Filing13 Jul 2026
Filing
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 12 Aug 2026.